Trial Profile
Ceftaroline fosamil in patients with MRSA bacteraemia
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 12 Jan 2014
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Bacteraemia; Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 12 Jan 2014 New trial record